Nabriva Therapeutics plc

Nabriva Therapeutics plcverified

NBRV

Price:

$1.42

Market Cap:

$4.55M

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomye...[Read more]

Industry

Biotechnology

IPO Date

2017-06-23

Stock Exchange

NASDAQ

Ticker

NBRV

The Enterprise Value as of November 2024 (TTM) for Nabriva Therapeutics plc (NBRV) is 3.29M

According to Nabriva Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is 3.29M. This represents a change of -753.46% compared to the average of -503485.32 of the last 4 quarters.

Nabriva Therapeutics plc (NBRV) Historical Enterprise Value (quarterly & annually)

How has NBRV Enterprise Value performed in the past?

The mean historical Enterprise Value of Nabriva Therapeutics plc over the last ten years is 17.80M. The current 3.29M Enterprise Value has changed 1.75% with respect to the historical average. Over the past ten years (40 quarters), NBRV's Enterprise Value was at its highest in in the December 2018 quarter at 18.54T. The Enterprise Value was at its lowest in in the December 2017 quarter at -86537000.00.

Quarterly (TTM)
Annual

Average

17.80M

Median

-2335469.24

Minimum

-26418917.50

Maximum

91.85M

Nabriva Therapeutics plc (NBRV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nabriva Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 436.62%

Maximum Annual Enterprise Value = 91.85M

Minimum Annual Increase = -1225.97%

Minimum Annual Enterprise Value = -26418917.50

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022-2124080.48-84.46%
2021-13667014.39436.62%
2020-2546858.00-105.49%
201946.43M-1225.97%
2018-4123205.00-104.49%
201791.85M-559.78%
2016-19976963.00-24.38%
2015-26418917.50-143.54%
201460.68M26.74%

Nabriva Therapeutics plc (NBRV) Average Enterprise Value

How has NBRV Enterprise Value performed in the past?

The current Enterprise Value of Nabriva Therapeutics plc (NBRV) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-6112650.96

5-year avg

4.79M

10-year avg

17.80M

Nabriva Therapeutics plc (NBRV) Enterprise Value vs. Peers

How is NBRV’s Enterprise Value compared to its peers?

Nabriva Therapeutics plc’s Enterprise Value is greater than Evoke Pharma, Inc. (508.40K), less than Trevena, Inc. (21.55M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), less than Paratek Pharmaceuticals, Inc. (344.90M), less than Clearside Biomedical, Inc. (106.34M),

CompanyEnterprise ValueMarket cap
508.40K$4.69M
21.55M$1.44M
-1447403.00$8.98M
344.90M$127.83M
106.34M$76.99M

Build a custom stock screener for Nabriva Therapeutics plc (NBRV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nabriva Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nabriva Therapeutics plc (NBRV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nabriva Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Nabriva Therapeutics plc's Enterprise Value?

What is the highest Enterprise Value for Nabriva Therapeutics plc (NBRV)?

What is the 3-year average Enterprise Value for Nabriva Therapeutics plc (NBRV)?

What is the 5-year average Enterprise Value for Nabriva Therapeutics plc (NBRV)?

How does the current Enterprise Value for Nabriva Therapeutics plc (NBRV) compare to its historical average?